Weinand Dieter is a director of Coya Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Replimune Group, Inc.
3 Apr 24
4
Coya Therapeutics, Inc.
19 Jan 24
4
Coya Therapeutics, Inc.
21 Aug 23
3
Coya Therapeutics, Inc.
21 Aug 23
4
Replimune Group, Inc.
4 Apr 23
4
Replimune Group, Inc.
5 Apr 22
4
Replimune Group, Inc.
5 Apr 21
4
Replimune Group, Inc.
2 Apr 20
4
Replimune Group, Inc.
3 Apr 19
4
Replimune Group, Inc.
26 Jul 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | REPL Replimune | Stock Option Common Stock | Grant | Acquire A | No | No | 7.73 | 32,000 | 247.36 k | 32,000 |
1 Jan 24 | COYA Coya Therapeutics | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 7.41 | 5,000 | 37.05 k | 5,000 |
18 Aug 23 | COYA Coya Therapeutics | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 3.43 | 10,000 | 34.30 k | 10,000 |
1 Apr 23 | REPL Replimune | Stock Option Common Stock | Grant | Acquire A | No | No | 17.66 | 37,800 | 667.55 k | 37,800 |